{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/VRAX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-16T01:23:16.061Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":12727,"canonical_name":"Virax Biolabs Group Ltd","cik":"0001885827","uei":null,"lei":null,"duns":null,"ticker":"VRAX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":16},"count":16,"timeline":[{"ts":"2026-10-09","kind":"sec.filing","form_type":"6-K","title":"6-K — Virax Biolabs Group Ltd — 2026-10-09","url_slug":"/sec/cik-0001885827/6-k/0001193125-26-419117","accession_number":"0001193125-26-419117","importance":30},{"ts":"2026-09-10","kind":"sec.filing","form_type":"424B3","title":"424B3 — Virax Biolabs Group Ltd — 2026-09-10","url_slug":"/sec/cik-0001885827/424b3/0001193125-26-386697","accession_number":"0001193125-26-386697","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"424B5","title":"424B5 — Virax Biolabs Group Ltd — 2026-09-04","url_slug":"/sec/cik-0001885827/424b5/0001193125-26-383658","accession_number":"0001193125-26-383658","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"6-K","title":"6-K — Virax Biolabs Group Ltd — 2026-09-04","url_slug":"/sec/cik-0001885827/6-k/0001193125-26-383683","accession_number":"0001193125-26-383683","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Virax Biolabs Group Ltd — 2026-09-03","url_slug":"/sec/cik-0001885827/effect/9999999995-26-002878","accession_number":"9999999995-26-002878","importance":30},{"ts":"2026-09-02","kind":"sec.filing","form_type":"F-3/A","title":"F-3/A — Virax Biolabs Group Ltd — 2026-09-02","url_slug":"/sec/cik-0001885827/f-3-a/0001193125-26-380474","accession_number":"0001193125-26-380474","importance":30},{"ts":"2026-08-26","kind":"sec.filing","form_type":"6-K","title":"6-K — Virax Biolabs Group Ltd — 2026-08-26","url_slug":"/sec/cik-0001885827/6-k/0001193125-26-368710","accession_number":"0001193125-26-368710","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"6-K","title":"6-K — Virax Biolabs Group Ltd — 2026-08-18","url_slug":"/sec/cik-0001885827/6-k/0001193125-26-354722","accession_number":"0001193125-26-354722","importance":30},{"ts":"2026-07-31","kind":"sec.filing","form_type":"6-K","title":"6-K — Virax Biolabs Group Ltd — 2026-07-31","url_slug":"/sec/cik-0001885827/6-k/0001193125-26-326851","accession_number":"0001193125-26-326851","importance":30},{"ts":"2026-07-24","kind":"sec.filing","form_type":"F-3","title":"F-3 — Virax Biolabs Group Ltd — 2026-07-24","url_slug":"/sec/cik-0001885827/f-3/0001193125-26-316130","accession_number":"0001193125-26-316130","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"6-K","title":"6-K — Virax Biolabs Group Ltd — 2026-07-16","url_slug":"/sec/cik-0001885827/6-k/0001193125-26-305400","accession_number":"0001193125-26-305400","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"6-K","title":"6-K — Virax Biolabs Group Ltd — 2026-07-10","url_slug":"/sec/cik-0001885827/6-k/0001193125-26-300880","accession_number":"0001193125-26-300880","importance":30},{"ts":"2026-07-09","kind":"sec.filing","form_type":"6-K","title":"6-K — Virax Biolabs Group Ltd — 2026-07-09","url_slug":"/sec/cik-0001885827/6-k/0001193125-26-299132","accession_number":"0001193125-26-299132","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"20-F","title":"20-F — Virax Biolabs Group Ltd — 2026-07-06","url_slug":"/sec/cik-0001885827/20-f/0001193125-26-295158","accession_number":"0001193125-26-295158","importance":30},{"ts":"2026-06-24","kind":"sec.filing","form_type":"6-K","title":"6-K — Virax Biolabs Group Ltd — 2026-06-24","url_slug":"/sec/cik-0001885827/6-k/0001193125-26-281196","accession_number":"0001193125-26-281196","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"6-K","title":"6-K — Virax Biolabs Group Ltd — 2026-06-12","url_slug":"/sec/cik-0001885827/6-k/0001193125-26-268604","accession_number":"0001193125-26-268604","importance":30}]}